FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
February 9, 2006
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: February 9, 2006
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
Smith & Nephew senior management appointments
9 February 2006
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business,
announced today that it has made three new Business Unit President appointments
with immediate effect.
Smith & Nephew's Orthopaedics business has grown strongly in the last five
years, with performance consistently ahead of its markets. To develop this
business further, we are now identifying two separate business units;
Orthopaedic Reconstruction and Orthopaedic Trauma (including Clinical
Therapies). This change is at the heart of our strategy to focus our businesses
on the markets and customers that they serve.
Scott Flora, currently Senior Vice-President and General Manager of the
Reconstructive Division, is promoted to President Orthopaedic Reconstruction.
Scott has over 20 years experience in the medical device industry including
working with companies such as Johnson & Johnson. He joined Smith & Nephew in
1986 as a sales representative and was progressively promoted becoming Senior
Vice-President of Trauma and Clinical Therapies Division in 2003. In March 2005
he was appointed to his current role.
Mark Augusti is promoted to President Orthopaedic Trauma and Clinical Therapies.
Mark started his career in sales with GE Medical Systems and spent 13 years
there in a number of roles based in the US and Asia. He joined Smith & Nephew
in April 2003 as Vice President of Global Marketing for the Trauma Division and
was promoted to Senior Vice-President and General Manager Trauma Division in
March 2005.
After 30 years with Smith & Nephew, the last seven years as President of
Advanced Wound Management, Jim Dick will be retiring in the summer of this year.
Joe Woody, currently the Vice President and General Manager of the Clinical
Therapies Division, has been appointed as Jim's successor as President of
Advanced Wound Management. Joe has 20 years experience in marketing and sales
and worked for Alliance Imaging, Acuson and GE Medical Systems before joining
Smith & Nephew in 2003. Under his leadership Clinical Therapies has grown
rapidly into a significant business. Joe will re-locate to the UK to take up
his new role.
Sir Christopher O'Donnell, Chief Executive of Smith & Nephew, commenting on
these appointments today said:
"Smith & Nephew's Orthopaedics business has grown substantially in recent years
with performance consistently ahead of its markets. As a consequence of
segmenting our Orthopaedics business we are able to promote two highly talented
people to President. The appointment of Scott Flora and Mark Augusti coincide
with an exciting time for these businesses with excellent opportunities for
continued above market growth."
"Joe Woody has made a major contribution in leading the excellent growth
achieved by Clinical Therapies. We look forward to benefiting from his broad
experience in sales and marketing, particularly in the United States, in
accelerating growth in our Advanced Wound Management business."
Commenting on Jim Dick's retirement, Christopher O'Donnell added: "Under Jim
Advanced Wound Management has evolved into a global leader with strong market
positions in all major countries of the world. I would like to thank Jim for
his contribution to the Group over many years."
Enquiries
Investors
Sir Christopher O'Donnell Tel: +44 (0) 20 7401 7646
Smith & Nephew
Chief Executive
Investors / Media
Liz Hewitt Tel: +44 (0) 20 7401 7646
Smith & Nephew
Group Director Corporate Affairs
About us
Smith & Nephew is a global medical technology business, specialising in
Orthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephew
is a global leader in arthroscopy and advanced wound management and is one of
the fastest growing global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust. The company has over 8,500
employees and operates in 33 countries around the world generating annual sales
of $2.6 billion.